Clinical Trials Browser

Active not recruiting × padeliporfin × Genitourinary × Clear all

NCT03315754 2024-12-20

Study of the Efficacy, Safety and Quality of Life After TOOKAD® Soluble (VTP) for Intermediate Risk Prostate Cancer.

Phase 2 Active not recruiting

50 enrolled 8 charts

Localized Prostate Cancer